Algo version: 0.98b
EIS Eczacibasi Ilac Sinai is listed at the IST Exchange
EIS Eczacibasi Ilac Sinai [ECILC.IS]
IST Sector: Healthcare Industry:Drug Manufacturers General

Is EIS Eczacibasi Ilac Sinai stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, EIS Eczacibasi Ilac Sinai pays dividends. Last time was Friday 7th of June 2024 where the investors holding the stock on Wednesday 5th of June 2024 were paid TRY1.18 per share. Over the last 19 times between 2004 and 2024, EIS Eczacibasi Ilac Sinai has paid TRY4.3446 with an average of TRY0.23 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for EIS Eczacibasi Ilac Sinai 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TRY3.41, you would have made a profit of TRY42.21 per share or 1 237.83%

Yes, the average daily trading liquidity for EIS Eczacibasi Ilac Sinai is TRY3.75 million. You should therefore be able to get in and out of your positions relatively fast.

EIS Eczacibasi Ilac Sinai has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.59, the company's ability to pay off the debt is good. EIS Eczacibasi Ilac Sinai has a very good net profit margin of 41.11% and should have very high tolerances against inflation.

We have calculated the inflation risk for EIS Eczacibasi Ilac Sinai to be low [0 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.